Table 2 Details on genomic testing with ODxTT and Rapid-Neo CGP (n = 68).

From: Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II–III non-small cell lung cancer

Factors

Value

TAT (days)

 ODxTT

10 [5–19]

 CGP

28 [15–45]

TCC on CGP analysis

 Pathology

50 [30–80]

 Genomic

40 [10–80]

 Correlation coefficient

0.489

 DNA depth on CGP analysis

236 [76–416]

  1. Values are presented as median [range], except for the correlation coefficient.
  2. CGP, comprehensive genomic profiling; ODxTT, Oncomine Dx Target Test; TAT, turnaround time; TCC, tumor cell content.
Back to article page